Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial, and learning & development, announces that it has acquired Bridge Medical Consulting, a specialized health economics and outcomes research (HEOR) consultancy. The acquisition represents a key step in Red Nucleus’s strategy, strengthening its ability to help biopharmaceutical companies demonstrate the clinical and economic value of increasingly specialized therapies in a complex regulatory and reimbursement environment and bolstering its current set of capabilities within HEOR.
Read the full article: Red Nucleus to Acquire Bridge Medical Consulting, Expanding Health Economics and Outcomes Research Capabilities //
Source: https://www.businesswire.com/news/home/20260202142734/en/Red-Nucleus-to-Acquire-Bridge-Medical-Consulting-Expanding-Health-Economics-and-Outcomes-Research-Capabilities